By Kimberly Chin

 

Koninklijke Philips N.V. said the U.S. Food and Drug Administration has given it a 501(k) clearance that allows it to expand its acute-care patient monitors to more people across the U.S.

The company said the advanced patient monitors support scalability, alarm management, cybersecurity and infection protection within a hospital setting. The monitors are interoperable with other devices and applications and can allow hospitals to standardize and customize patient care, it said.

Philips Patient Monitors IntelliVue MX750 and MX850 received emergency use authorization by the FDA in 2020.

 

Write to Kimberly Chin at kimberly.chin@wsj.com

 

(END) Dow Jones Newswires

December 08, 2021 09:42 ET (14:42 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Koninklijke Philips NV Charts.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Koninklijke Philips NV Charts.